An Open-label, Cross Over Study, to Assess the Interactions of Pantoprazole (Proton Pump Inhibitor) With Oral Cladribine Administered in Subjects With Multiple Sclerosis.
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2016
At a glance
- Drugs Cladribine; Pantoprazole
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors EMD Serono
- 10 Jan 2012 Primary endpoints identified as reported by ClinicalTrials.gov.
- 21 Jul 2009 New trial record